Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.
Pembrolizumab plus platinum-based therapy shows safety, efficacy in penile cancer
June 4th 2024“The HERCULES trial is the first trial to demonstrate the efficacy of immune checkpoint inhibitors in [patients with] advanced penile cancer with [a] manageable safety profile," says Fernando Cotait Maluf, MD.
Tibial neurostimulation system demonstrates safety and efficacy in urge urinary incontinence
April 30th 2023“We looked at safety issues within 12 months after the implantation, and they were minor—some pain problems, some wound-healing problems, but no serious adverse events,” said John Heesakkers, MD, PhD.
Hypertension predicts worse outcomes for patients undergoing nephroureterectomy for UTUC
April 30th 2023“What we found is that hypertension is an independent risk factor for worsened survival outcomes and mortality outcomes across the board on multivariable and Kaplan Meier analysis,” said Sohail Dhanji, MD.